摘要
目的:观察尪痹片联合美洛昔康治疗膝骨关节炎(KOA)的临床疗效。方法:将60例KOA患者随机分为对照组与治疗组各30例。对照组给予美洛昔康治疗,治疗组在对照组的基础上联合尪痹片治疗,治疗8周后对2组临床疗效进行统计观察,并对2组治疗前后中医证候积分、疼痛视觉模拟评分法(VAS)评分进行评定。结果:治疗组总有效率为93.33%,对照组为80.00%,2组比较,差异有统计学意义(P<0.05)。治疗前,2组中医证候积分比较,差异无统计学意义(P>0.05);治疗后,2组中医证候积分均较治疗前明显下降(P<0.05),治疗组中医证候积分低于对照组(P<0.05)。治疗前,2组VAS评分比较,差异无统计学意义(P>0.05);治疗后,2组VAS评分均较治疗前明显降低(P<0.05),且治疗组VAS评分低于对照组(P<0.05)。结论:尪痹片联合美洛昔康治疗KOA可提高临床疗效,缓解患者临床症状。
Objective:To observe the clinical effect of Wangbi tablets combined with meloxicam for knee osteoarthritis(KOA). Methods:A total of 60 cases of KOA patients were randomly divided into the control group and the treatment group,30 cases in each group.The control group was given meloxicam, and the treatment group was additionally given Wangbi tablets based on the treatment of the control group.After eight-week treatment,the clinical effect was observed in the two groups;Chinese medicine syndrome scores and score of Visual Analogue Scale(VAS) for evaluating pain before and after treatment were compared in the two groups. Results: The total effective rate was 93.33% in the treatment group, and80.00% in the control group,the difference being significant(P<0.05). Before treatment,there was no significant difference being found in the comparison of Chinese medicine syndrome scores between the two groups(P>0.05). After treatment,Chinese medicine syndrome scores in the two groups were significantly decreased when compared with those before treatment(P<0.05), and the scores in the treatment group were lower than those in the control group(P<0.05). Before treatment,there was no significant difference being found in the comparison of scores of VAS between the two groups(P>0.05). After treatment, scores of VAS in the two groups were significantly decreased when compared with those before treatment(P<0.05),and the score in the treatment group was lower than that in the control group(P<0.05). Conclusion:The therapy of Wangbi tablets combined with meloxicam can effectively enhance clinical effect and relieve clinical symptoms in the treatment of KOA.
作者
陶江涛
马玉
张敏
TAO Jiangtao;MA Yu;ZHANG Min
出处
《新中医》
CAS
2021年第11期85-87,共3页
New Chinese Medicine
关键词
膝骨关节炎
尪痹片
美洛昔康
中医证候积分
Knee osteoarthritis
Wangbi tablets
Meloxicam
Chinese medicine syndrome scores
